SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-371258
Filing Date
2017-12-18
Accepted
2017-12-18 07:46:03
Documents
4
Period of Report
2017-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d465337d8k.htm 8-K 16242
2 EX-99.1 d465337dex991.htm EX-99.1 14764
3 GRAPHIC g465337g07w42.jpg GRAPHIC 1789
4 GRAPHIC g465337g64g33.jpg GRAPHIC 14792
  Complete submission text file 0001193125-17-371258.txt   55391
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 171260332
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences